TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -3.18%1.41B | ---- | -61.55%1.46B | ---- | -12.20%3.79B | ---- | 7.49%4.32B | ---- | -34.39%4.02B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 28.44%-19.19M | ---- | 12.71%-26.82M | ---- | 10.95%-30.73M | ---- | 17.81%-34.51M | ---- | -103.95%-41.98M |
Attributable subsidiary (profit) loss | ---- | -6,039.29%-1.72M | ---- | -102.38%-28K | ---- | -86.61%1.18M | ---- | --8.77M | ---- | ---- |
Impairment and provisions: | ---- | 107.05%10.24M | ---- | -1,224.60%-145.21M | ---- | 121.53%12.91M | ---- | -209.92%-59.96M | ---- | -19.71%54.55M |
-Impairment of trade receivables (reversal) | ---- | 107.05%10.24M | ---- | -1,224.60%-145.21M | ---- | 121.53%12.91M | ---- | -209.92%-59.96M | ---- | -19.71%54.55M |
Revaluation surplus: | ---- | 136.13%172K | ---- | -1,460.00%-476K | ---- | 100.72%35K | ---- | 15.49%-4.85M | ---- | -117.59%-5.74M |
-Derivative financial instruments fair value (increase) | ---- | 136.13%172K | ---- | -1,460.00%-476K | ---- | 100.72%35K | ---- | 15.49%-4.85M | ---- | -117.59%-5.74M |
Asset sale loss (gain): | ---- | -56.59%4.05M | ---- | -83.67%9.32M | ---- | 1,039.26%57.08M | ---- | -31.96%5.01M | ---- | -31.68%7.36M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---21.26M | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -82.93%4.05M | ---- | -69.75%23.7M | ---- | 1,463.69%78.34M | ---- | -31.96%5.01M | ---- | -31.68%7.36M |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---14.38M | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | -8.85%174.55M | ---- | 15.88%191.5M | ---- | -3.62%165.25M | ---- | 12.95%171.45M | ---- | 9.40%151.79M |
-Depreciation | ---- | -8.85%174.55M | ---- | 15.88%191.5M | ---- | -3.62%165.25M | ---- | 12.95%171.45M | ---- | 9.40%151.79M |
Financial expense | ---- | 124.71%278.12M | ---- | 64.17%123.77M | ---- | -55.79%75.39M | ---- | -47.51%170.52M | ---- | 1.64%324.86M |
Operating profit before the change of operating capital | ---- | 15.38%1.86B | ---- | -60.48%1.61B | ---- | -10.98%4.08B | ---- | 1.48%4.58B | ---- | -32.07%4.51B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -8.47%1.26B | ---- | 416.77%1.37B | ---- | -63.10%265.91M | ---- | -68.85%720.59M | ---- | 115.80%2.31B |
Accounts receivable (increase)decrease | ---- | -835.71%-1.72B | ---- | 120.40%233.44M | ---- | -58.32%-1.14B | ---- | -551.80%-722.7M | ---- | -69.77%159.96M |
Accounts payable increase (decrease) | ---- | -123.84%-248.05M | ---- | 183.14%1.04B | ---- | 344.15%367.43M | ---- | 81.66%-150.49M | ---- | -25.60%-820.72M |
Derivative financial instruments (increase) decrease | ---- | -136.13%-172K | ---- | 1,460.00%476K | ---- | -100.72%-35K | ---- | 120.36%4.85M | ---- | -78.66%2.2M |
Cash from business operations | ---- | -72.98%1.15B | ---- | 19.49%4.26B | ---- | -19.54%3.56B | ---- | -28.15%4.43B | ---- | -18.87%6.17B |
China income tax paid | ---- | 9.61%-172.12M | ---- | 65.57%-190.43M | ---- | -3.44%-553.01M | ---- | 7.12%-534.64M | ---- | 37.52%-575.65M |
Other taxs | ---- | ---- | ---- | ---- | ---- | 84.75%-30.69M | ---- | 7.99%-201.23M | ---- | -42.18%-218.7M |
Interest paid - operating | ---- | -128.97%-827.17M | ---- | -91.09%-361.26M | ---- | 39.32%-189.05M | ---- | 24.94%-311.55M | ---- | -6.66%-415.05M |
Special items of business | -90.52%161.1M | ---- | 100.35%1.7B | ---- | 140.00%848.32M | ---- | -68.99%353.47M | ---- | -39.57%1.14B | ---- |
Net cash from operations | -90.52%161.1M | -95.92%151.37M | 100.35%1.7B | 32.80%3.71B | 140.00%848.32M | -17.47%2.79B | -68.99%353.47M | -31.75%3.38B | -39.57%1.14B | -19.21%4.96B |
Cash flow from investment activities | ||||||||||
Interest received - investment | -19.03%7.15M | -28.44%19.19M | -31.41%8.83M | -12.71%26.82M | 65.60%12.87M | -10.95%30.73M | -64.70%7.77M | -17.81%34.51M | 76.56%22.02M | 103.95%41.98M |
Loan receivable (increase) decrease | 286,775.00%11.47M | -109.28%-881K | 99.61%-4K | 392.06%9.49M | -229.39%-1.03M | -42.61%-3.25M | 90.60%-313K | 67.09%-2.28M | 41.13%-3.33M | 68.82%-6.92M |
Sale of fixed assets | -56.38%1.35M | 284.90%44.16M | -83.33%3.1M | -81.45%11.47M | 1,360.16%18.62M | 1,263.95%61.86M | 2.16%1.28M | -67.64%4.54M | -78.28%1.25M | -64.10%14.02M |
Purchase of fixed assets | 47.72%-1.39B | 27.37%-2.9B | -33.87%-2.65B | -72.79%-4B | -10.92%-1.98B | 0.81%-2.31B | -24.66%-1.79B | 33.68%-2.33B | 9.65%-1.43B | -53.43%-3.52B |
Purchase of intangible assets | ---4.4M | -952.27%-281.59M | ---- | -103.50%-26.76M | ---- | 32.83%-13.15M | ---6.72M | 62.41%-19.58M | ---- | ---52.08M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | --113.16M | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | -2,325.19%-391.28M | ---- | ---16.13M | ---- | ---- |
Cash on investment | 49.83%-7.99M | 24.19%-545.43M | ---15.93M | 27.48%-719.44M | ---- | -0.18%-992.01M | ---- | -43,236.81%-990.25M | ---- | 54.72%-2.29M |
Other items in the investment business | ---- | ---- | --578K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | 48.07%-1.38B | 21.89%-3.67B | -36.14%-2.65B | -33.87%-4.69B | -9.34%-1.95B | -5.60%-3.51B | -26.28%-1.78B | 5.68%-3.32B | 11.22%-1.41B | -55.86%-3.52B |
Net cash before financing | -27.52%-1.22B | -256.18%-3.52B | 13.33%-954.38M | -38.06%-987.05M | 22.97%-1.1B | -1,255.19%-714.94M | -425.23%-1.43B | -95.69%61.89M | -191.98%-272.18M | -62.97%1.44B |
Cash flow from financing activities | ||||||||||
New borrowing | 86.26%2.71B | 32.53%25.04B | -1.28%1.45B | 13.25%18.89B | -44.75%1.47B | 36.85%16.68B | 729.68%2.66B | -27.20%12.19B | 18.63%321.01M | 4.44%16.74B |
Refund | ---- | -32.68%-22.07B | ---- | -18.85%-16.63B | ---- | -6.03%-13.99B | ---- | 27.49%-13.2B | ---- | -5.09%-18.2B |
Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.32B |
Dividends paid - financing | -84.24%-262.02M | 66.92%-249.96M | 70.06%-142.22M | 47.33%-755.5M | 39.30%-474.93M | -32.00%-1.43B | -38.46%-782.4M | 11.33%-1.09B | 13.99%-565.06M | 31.00%-1.23B |
Issuance expenses and redemption of securities expenses | -44,814.55%-1.67B | 60.24%-196.92M | 95.12%-3.72M | -510.77%-495.28M | ---76.19M | 15.41%-81.09M | ---- | -1.30%-95.86M | -135.01%-95.86M | 90.21%-94.63M |
Other items of the financing business | 903.02%692.58M | 763.08%734.01M | -56.66%69.05M | -70.30%85.05M | 348.65%159.34M | -30.35%286.37M | 1.03%-64.08M | 735.24%411.13M | ---64.75M | ---64.72M |
Net cash from financing operations | 6.91%1.45B | 206.72%3.24B | 27.10%1.36B | -26.44%1.06B | -41.13%1.07B | 179.97%1.43B | 542.89%1.82B | -238.56%-1.79B | -121.66%-410.22M | 86.84%-529.81M |
Effect of rate | -126.11%-7.09M | 98.96%-1.85M | 159.48%27.15M | -4,107.34%-178.61M | ---45.65M | 265.56%4.46M | ---- | -221.10%-2.69M | ---- | 102.60%2.22M |
Net Cash | -41.66%236.31M | -510.09%-279.32M | 1,379.84%405.04M | -90.53%68.11M | -108.17%-31.65M | 141.54%719.44M | 156.75%387.29M | -291.30%-1.73B | -131.16%-682.4M | 698.61%905.3M |
Begining period cash | -15.64%1.52B | -5.79%1.8B | -5.79%1.8B | 61.09%1.91B | 61.09%1.91B | -59.41%1.18B | -59.41%1.18B | 45.11%2.92B | 45.11%2.92B | -10.53%2.01B |
Cash at the end | -21.71%1.75B | -15.64%1.52B | 21.79%2.23B | -5.79%1.8B | 16.49%1.83B | 61.09%1.91B | -29.72%1.57B | -59.41%1.18B | -46.76%2.24B | 45.11%2.92B |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.